Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 11 March 2021
EventHumanCOVID-19
Latvian is available via eTranslation, the European Commission's machine translation service.
Translate to Latvian | Important information about machine translation
Date
- Ceturtdiena, 11 Marts 2021, Visu dienu
Vieta
- OnlineEuropean Medicines Agency, Amsterdam, the Netherlands
This extraordinary meeting is organised in the context of the evaluation ofJcovden (previously COVID-19 Vaccine Janssen) developed by Janssen-Cilag International N.V.
The aim of the meeting is to conclude the evaluation, if possible.
The Committee for Medicinal Products for Human Use (CHMP) is the committee that is responsible for preparing the Agency's opinions on all questions concerning human medicines.